HSITF (Hadasit Bio Holdings) Other Financing: $-0.39 Mil (TTM As of Dec. 2025)


HSITF Hadasit Bio Holdings Ltd HSITF
14 GF Score
Price $0.12
! 3 Warning Signs
View Full Analysis

What is Hadasit Bio Holdings Other Financing?

Hadasit Bio Holdings HSITF 14 Other Financing is $-0.39 Mil as of Dec. 2025. GuruFocus rates HSITF with a GF Score™ of 14/100. The stock has 3 warning signs investors should review.

Hadasit Bio Holdings's Other Financing for the six months ended in Dec. 2025 was $-0.39 Mil.

Hadasit Bio Holdings's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.39 Mil.

Hadasit Bio Holdings Other Financing Historical Data

* Premium members only.

The historical data trend for Hadasit Bio Holdings's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hadasit Bio Holdings Other Financing Chart

Hadasit Bio Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 -0.08 -0.05 -0.02

Hadasit Bio Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.00 0.52 0.00 -0.39
HSITF
14GF Score
Hadasit Bio Holdings Ltd HSITF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hadasit Bio Holdings Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-0.39 Mil mean?
Hadasit Bio Holdings (HSITF) has a Other Financing of $-0.39 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Hadasit Bio Holdings and its competitors.
Is Hadasit Bio Holdings' Other Financing too high?
Hadasit Bio Holdings' current Other Financing is $-0.39 Mil. Overall, Hadasit Bio Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Hadasit Bio Holdings' Other Financing compare to VRTX and REGN?
Hadasit Bio Holdings' Other Financing of $-0.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Hadasit Bio Holdings and its competitors. Hadasit Bio Holdings's current Other Financing is $-0.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hadasit Bio Holdings stock overvalued right now?
Hadasit Bio Holdings (HSITF) has a current Other Financing of $-0.39 Mil. The current Other Financing is $-0.39 Mil. Hadasit Bio Holdings' overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Hadasit Bio Holdings (HSITF), the current Other Financing is $-0.39 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hadasit Bio Holdings Business Description

Other Exchanges HDST-M:Israel
Address 5th Floor, Jerusaelm Bio-Park, Hadassah Ein-Kerem Campus, Jerusalem, ISR, 91120
Hadasit Bio Holdings Ltd serves as a precedent in the field of biotech financing. It is engaged in the advancement and enhancement of its portfolio companies. Its portfolio companies are involved in the field of medical and biotechnological research and production and distribution of the results of the research and development done in these areas.
14GF Score

Get the complete analysis for HSITF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price